1. Home
  2. IMRN vs BBGI Comparison

IMRN vs BBGI Comparison

Compare IMRN & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • BBGI
  • Stock Information
  • Founded
  • IMRN 1994
  • BBGI 1961
  • Country
  • IMRN Australia
  • BBGI United States
  • Employees
  • IMRN N/A
  • BBGI N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • BBGI Broadcasting
  • Sector
  • IMRN Health Care
  • BBGI Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • BBGI Nasdaq
  • Market Cap
  • IMRN 9.2M
  • BBGI 8.1M
  • IPO Year
  • IMRN N/A
  • BBGI 2000
  • Fundamental
  • Price
  • IMRN $1.88
  • BBGI $3.90
  • Analyst Decision
  • IMRN Strong Buy
  • BBGI
  • Analyst Count
  • IMRN 1
  • BBGI 0
  • Target Price
  • IMRN $5.00
  • BBGI N/A
  • AVG Volume (30 Days)
  • IMRN 25.2K
  • BBGI 75.8K
  • Earning Date
  • IMRN 07-07-2025
  • BBGI 08-11-2025
  • Dividend Yield
  • IMRN N/A
  • BBGI N/A
  • EPS Growth
  • IMRN N/A
  • BBGI N/A
  • EPS
  • IMRN N/A
  • BBGI N/A
  • Revenue
  • IMRN $4,048,286.00
  • BBGI $234,823,730.00
  • Revenue This Year
  • IMRN N/A
  • BBGI $5.02
  • Revenue Next Year
  • IMRN N/A
  • BBGI N/A
  • P/E Ratio
  • IMRN N/A
  • BBGI N/A
  • Revenue Growth
  • IMRN 82.90
  • BBGI N/A
  • 52 Week Low
  • IMRN $1.50
  • BBGI $3.67
  • 52 Week High
  • IMRN $2.87
  • BBGI $14.95
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 58.70
  • BBGI 33.07
  • Support Level
  • IMRN $1.68
  • BBGI $3.67
  • Resistance Level
  • IMRN $1.94
  • BBGI $5.26
  • Average True Range (ATR)
  • IMRN 0.09
  • BBGI 0.29
  • MACD
  • IMRN 0.02
  • BBGI -0.04
  • Stochastic Oscillator
  • IMRN 76.92
  • BBGI 14.47

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

Share on Social Networks: